SBP GROUP (01177) plans to allocate up to 2 billion Hong Kong dollars for share repurchases and reward stock purchases.

date
06:06 15/06/2026
avatar
GMT Eight
China Biopharmaceuticals (01177) announced that on June 12, 2026, the board of directors approved a share purchase plan. According to this plan, the company will, depending on market conditions, in the next 12 months, purchase shares in the open market with a total cost not exceeding 2 billion Hong Kong dollars, (1) in accordance with the share repurchase authorization granted at the annual general meeting of shareholders, and subject to its terms and conditions, repurchase shares, and (2) in accordance with the restricted share award plan adopted by the company on January 5, 2018, instruct the trustee responsible for managing the share award plan to purchase shares. The board of directors will periodically review and have full discretion to decide how to allocate the share purchase limit for share repurchases and award share purchases.
SBP GROUP (01177) announced that on June 12, 2026, the Board of Directors approved a share purchase plan, under which the company will, depending on market conditions, purchase shares in the open market for a total consideration not exceeding HK$2 billion in the next 12 months. The purchases will be made (1) based on the share repurchase authorization granted at the annual general meeting of shareholders, subject to its terms and conditions, and (2) based on the restricted share award plan adopted by the company on January 5, 2018, instructing the trustee responsible for managing the share award plan to purchase shares. The Board of Directors will periodically review and have full discretion to determine how to allocate the share purchase quota for share repurchase and award share purchase. Since the beginning of 2026, the company has also purchased (including repurchases and instructions for the trustee to purchase shares under the share award plan) 60.35 million shares, for a total consideration of approximately HK$338 million. The Board of Directors believes that implementing the share purchase plan is in the overall best interests of the company and its shareholders. Conducting share purchases at the current juncture demonstrates the company's confidence in its business outlook and prospects, and will ultimately benefit the company and create value for shareholders. The Board of Directors believes that the company's existing financial resources are sufficient to implement the share purchase plan and maintain a sound financial position.